Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue
- PMID: 20103667
- DOI: 10.1158/1078-0432.CCR-09-2718
Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue
Abstract
Purpose: The interstitial fluid pressure (IFP) of the primary tumor is an independent prognostic parameter for cervical cancer patients treated with radiation therapy. The aim of this preclinical study was to investigate whether tumor radiocurability may be associated with IFP through hypoxia-independent mechanisms.
Experimental design: Small A-07 and R-18 melanoma xenografts without hypoxic tissue were used as preclinical tumor models. IFP was measured by using the wick-in-needle method. Radiation dose resulting in 50% local tumor control (TCD(50)), cell density, cell tumorigenicity, plating efficiency in vitro, mitotic index, fraction of Ki67-positive cells, vascular endothelial growth factor-A (VEGF-A) concentration, and radiation-induced endothelial cell apoptosis were assessed in tumors with low and high IFP.
Results: TCD(50) was found to be higher for tumors with high IFP than for tumors with low IFP by factors of 1.13 +/- 0.03 (A-07; P < 0.0001) and 1.10 +/- 0.03 (R-18; P < 0.0001). In the A-07 line, tumors with high IFP showed a larger number of clonogenic cells and a higher rate of cell proliferation than tumors with low IFP. In the R-18 line, tumors with high IFP showed a higher concentration of VEGF-A and a lower endothelial cell apoptotic index after irradiation than tumors with low IFP.
Conclusions: The radiation resistance of normoxic tumor tissue with highly elevated IFP may be an indirect consequence of increased tumor cell clonogenicity as well as increased VEGF-A expression, possibly caused by hypertension-induced modifications of signaling pathways regulating cell proliferation, cell survival, and/or angiogenesis.
Similar articles
-
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.Cancer Res. 2000 Oct 1;60(19):5565-70. Cancer Res. 2000. PMID: 11034104
-
Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts.Cancer Res. 2002 Feb 1;62(3):661-4. Cancer Res. 2002. PMID: 11830516
-
Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors.Cancer Res. 2006 Feb 15;66(4):2074-80. doi: 10.1158/0008-5472.CAN-05-2046. Cancer Res. 2006. PMID: 16489007
-
Interstitial fluid pressure as an emerging biomarker in solid tumors.Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188792. doi: 10.1016/j.bbcan.2022.188792. Epub 2022 Sep 7. Biochim Biophys Acta Rev Cancer. 2022. PMID: 36084861 Review.
-
Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis.Future Oncol. 2008 Dec;4(6):793-802. doi: 10.2217/14796694.4.6.793. Future Oncol. 2008. PMID: 19086846 Review.
Cited by
-
Cancer cells grown in 3D under fluid flow exhibit an aggressive phenotype and reduced responsiveness to the anti-cancer treatment doxorubicin.Sci Rep. 2020 Jul 21;10(1):12020. doi: 10.1038/s41598-020-68999-9. Sci Rep. 2020. PMID: 32694700 Free PMC article.
-
Estimation of Tumor Interstitial Fluid Pressure (TIFP) Noninvasively.PLoS One. 2016 Jul 28;11(7):e0140892. doi: 10.1371/journal.pone.0140892. eCollection 2016. PLoS One. 2016. PMID: 27467886 Free PMC article.
-
Tumor interstitial fluid and gastric cancer metastasis: an experimental study to verify the hypothesis of "tumor-phlegm microenvironment".Chin J Integr Med. 2012 May;18(5):350-8. doi: 10.1007/s11655-012-1085-z. Epub 2012 May 2. Chin J Integr Med. 2012. PMID: 22549391
-
Antifibrotic therapy to normalize the tumor microenvironment.J Transl Med. 2020 May 20;18(1):207. doi: 10.1186/s12967-020-02376-y. J Transl Med. 2020. PMID: 32434573 Free PMC article. Review.
-
Intratumor Heterogeneity in Interstitial Fluid Pressure in Cervical and Pancreatic Carcinoma Xenografts.Transl Oncol. 2019 Aug;12(8):1079-1085. doi: 10.1016/j.tranon.2019.05.012. Epub 2019 Jun 4. Transl Oncol. 2019. PMID: 31174058 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources